Annie and Nick speak with Dr. Robert Meisner, MD, medical director of McLean Hospital's Ketamine Service and a clinical fellow in psychiatry at Harvard Medical School, about the new frontier of depression treatment using the synthetic drug ketamine. Plus, they discuss the misuse of ketamine as a sedating agent by first responders, and the worrying menta…
Eyewitness Beauty
Ep 4: Ketamine: The Good, The Bad, The Future of Treating Depression?
Current time: 0:00 / Total time: -47:27
Eyewitness Beauty
To hear full new episodes and to browse our four-year archive, subscribe to our Substack at eyewitnessbeauty.substack.com (https://eyewitnessbeauty.substack.com/) .
“My favorite podcast.” — Emily Sundberg, Feed Me (https://www.readfeedme.com/)
“This one’s for the Into The Gloss (https://intothegloss.com/) Day Ones.” — Vogue
Brand founders, beauty editors, and creative-types Annie Kreighbaum (Glossier, Soft Services) and Nick Axelrod-Welk (Into The Gloss, Nécessaire) discuss industry news, start-up culture, and pop culture in their (mostly) weekly podcast, Eyewitness Beauty.
To hear full new episodes and to browse our four-year archive, subscribe to our Substack at eyewitnessbeauty.substack.com (https://eyewitnessbeauty.substack.com/) .
“My favorite podcast.” — Emily Sundberg, Feed Me (https://www.readfeedme.com/)
“This one’s for the Into The Gloss (https://intothegloss.com/) Day Ones.” — Vogue
Brand founders, beauty editors, and creative-types Annie Kreighbaum (Glossier, Soft Services) and Nick Axelrod-Welk (Into The Gloss, Nécessaire) discuss industry news, start-up culture, and pop culture in their (mostly) weekly podcast, Eyewitness Beauty.Listen on
Substack App
Apple Podcasts
Spotify
RSS Feed
Appears in episode
Eyewitness Beauty
